|
|
|
|
|
|
|
|
|
Webinar: From IND to Commercial Reality: Scaling Cell and Gene Therapy Manufacturing
|
What does it take to move a cell and gene therapy from development to commercial supply? Join us for a practical conversation on evolving CMC strategies, choosing the right commercialization partner, reducing batch costs, and navigating regulatory challenges. We’ll explore hidden inefficiencies, when to challenge conventional approaches, and how proactive lifecycle planning supports successful commercialization. Click here to learn more.
|
|
|
|
|
|
Webinar | MaxCyte, Inc.
|
Improve your gene editing and cell manufacturing with electroporation platforms and gene editing technology. Dive into the details of cell transfection technology, efficient gene knock-ins with mbDNA, and more.
|
|
|
|
|
|
Video | Thermo Fisher Scientific
|
Review these strategies for implementing and validating microbial identification systems, and a comprehensive solution that addresses challenges along the path.
|
|
|
|
|
|
Webinar | MilliporeSigma
|
Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.
|
|
|
|
|
|
Webinar | Andelyn Biosciences
|
Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.
|
|
|
|
|
|
Video | Cell & Gene
|
In this segment of Cell & Gene Live, Solving Vector Yield Challenges in In Vivo CGT, Karen Kozarsky, Ph.D., President and CSO of Vector BioPartners, and Robert Bell, Ph.D., CSO of Ascidian Therapeutics, focus on the tradeoffs between biological specificity, clinical precedent, manufacturability, and scalability.
|
|
|
|
|
|
Webinar | RoosterBio
|
Learn how to qualify analytical methods before entering clinical trials, including regulatory expectations, key parameters, and a hands-on walkthrough of the qualification process.
|
|
|
